Aptamers Market by Type, Application, Technology & by End Users - Global Forecast to 2020

The global aptamers market is expected to reach $244.93 million by 2020 from $107.56 million in 2015, growing at a CAGR of 17.89% between 2015 and 2020. The aptamer type segments included in this report are DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. Based on applications, the report is segmented into diagnostics, therapeutics development, R&D, and other applications. Diagnostics applications will hold the largest share of the aptamers market in 2015. The therapeutics development application is expected to be one of the fastest-growing applications between 2015 and 2020.

The geographic segments included in this report are the Americas, Europe, Asia, and the Rest of the World (RoW). The geographic analysis reveals that the Americas are expected to account for the largest share in the global aptamers market in 2015. Europe is expected to register the fastest growth.

Market growth is majorly driven by the availability of R&D investments in biotechnology and pharmaceutical industries. Furthermore, the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies will aid the growth of the global aptamers market.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global aptamers market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders.
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
‧ Product Development: Product portfolios of the top players in the aptamers market.
‧ Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the aptamers market.
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various aptamers products across geographies.

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.2.1 MARKET COVERED 15
1.2.2 YEARS CONSIDERED IN THE REPORT 15
1.3 CURRENCY 16
1.4 STAKEHOLDERS 16
1.5 LIMITATIONS 16
2 RESEARCH METHODOLOGY 17
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.2.1 KEY DATA FROM SECONDARY SOURCES 21
2.2.2 KEY DATA FROM PRIMARY SOURCES 21
2.2.3 ASSUMPTIONS FOR THE STUDY 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 26
4.1 LUCRATIVE OPPORTUNITIES IN THE GLOBAL APTAMERS MARKET 26
4.2 LIFE CYCLE ANALYSIS, BY REGION (2015–2020) 28
5 MARKET OVERVIEW 29
5.1 INTRODUCTION 30
5.2 MARKET SEGMENTATION 30
5.2.1 BY TYPE 30
5.2.2 BY APPLICATION 30
5.2.3 BY TECHNOLOGY 31
5.2.4 BY END USER 31
5.3 MARKET DYNAMICS 32
5.3.1 DRIVERS 32
5.3.1.1 Strong trend of R&D investments in biotechnology and pharmaceutical companies 32
5.3.1.2 Technological advancements 33
5.3.1.3 Patent expiration of SELEX 33
5.3.1.4 Low-cost and high-efficiency as compared to antibodies 34
5.3.2 RESTRAINTS 35
5.3.2.1 Low market acceptance 35
5.3.2.2 Lack of trained professionals 36
5.3.3 OPPORTUNITIES 36
5.3.3.1 Applications in other industries 36
6 APTAMERS MARKET, BY TYPE 38
6.1 INTRODUCTION 39
6.2 DNA-BASED APTAMERS 40
6.3 RNA-BASED APTAMERS 42
6.4 XNA-BASED APTAMERS 45
7 APTAMERS MARKET, BY APPLICATION 48
7.1 INTRODUCTION 49
7.2 DIAGNOSTICS 50
7.3 THERAPEUTICS DEVELOPMENT 53
7.4 RESEARCH AND DEVELOPMENT 56
7.5 OTHER APPLICATIONS 58
8 APTAMERS MARKET, BY TECHNOLOGY 60
8.1 INTRODUCTION 61
8.2 SELEX 62
8.3 OTHER TECHNOLOGIES 64
9 APTAMERS MARKET, BY END USER 67
9.1 INTRODUCTION 68
9.2 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES 69
9.3 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 71
9.4 CONTRACT RESEARCH ORGANIZATIONS 73
9.5 OTHER END USERS 75
10 GLOBAL APTAMERS MARKET, BY REGION 77
10.1 INTRODUCTION 78
10.2 AMERICAS 80
10.2.1 U.S. 87
10.2.2 CANADA 89
10.2.3 LATIN AMERICA 90
10.3 EUROPE 93
10.4 ASIA 99
10.5 REST OF THE WORLD (ROW) 103
?
11 COMPETITIVE LANDSCAPE 107
11.1 INTRODUCTION 107
11.2 COMPETITIVE SITUATION AND TRENDS 107
11.2.1 AGREEMENTS, COLLABORATIONS, EXPANSIONS, AND PARTNERSHIPS 108
11.2.2 CONTRACTS, DEVELOPMENT AGREEMENTS, FUNDING, GRANTS, AND REWARDS 109
11.2.3 NEW PRODUCT LAUNCHES 109
11.2.4 OTHER DEVELOPMENTS 110
12 COMPANY PROFILES 111
12.1 AM BIOTECHNOLOGIES, LLC 111
12.1.1 BUSINESS OVERVIEW 111
12.1.2 PRODUCT AND SERVICES 111
12.1.3 NEWS/EVENTS 112
12.2 APTAGEN, LLC 113
12.2.1 BUSINESS OVERVIEW 113
12.2.2 PRODUCT AND SERVICES 113
12.2.3 NEWS/EVENTS 113
12.3 APTAMER SCIENCES INC. 114
12.3.1 BUSINESS OVERVIEW 114
12.3.2 PRODUCT AND SERVICES 114
12.3.3 NEWS/EVENTS 115
12.4 APTAMER SOLUTIONS LTD. 116
12.4.1 BUSINESS OVERVIEW 116
12.4.2 PRODUCT AND SERVICES 116
12.4.3 NEWS/EVENTS 116
12.5 APTUS BIOTECH S.L. 117
12.5.1 BUSINESS OVERVIEW 117
12.5.2 PRODUCT AND SERVICES 117
12.5.3 NEWS/EVENTS 117
12.6 BASE PAIR BIOTECHNOLOGIES, INC. 119
12.6.1 BUSINESS OVERVIEW 119
12.6.2 PRODUCT AND SERVICES 119
12.6.3 NEWS/EVENTS 119
12.7 NEOVENTURES BIOTECHNOLOGY INC. 121
12.7.1 BUSINESS OVERVIEW 121
12.7.2 PRODUCT AND SERVICES 121
12.7.3 NEWS/EVENTS 121
12.8 SOMALOGIC, INC. 122
12.8.1 BUSINESS OVERVIEW 122
12.8.2 PRODUCT AND SERVICES 122
12.8.3 NEWS/EVENTS 122
12.9 TRILINK BIOTECHNOLOGIES, INC. 124
12.9.1 BUSINESS OVERVIEW 124
12.9.2 PRODUCT AND SERVICES 124
12.9.3 NEWS/EVENTS 124
12.10 VIVONICS, INC. 125
12.10.1 BUSINESS OVERVIEW 125
12.10.2 PRODUCT AND SERVICES 125
12.10.3 NEWS/EVENTS 125
13 APPENDIX 126
13.1 INSIGHTS OF INDUSTRY EXPERTS 126
13.2 DISCUSSION GUIDE 127
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 129
13.4 AVAILABLE CUSTOMIZATIONS 130
13.5 RELATED REPORTS 131